These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14744400)

  • 1. [The role of the host defense response in ARDS and sepsis and its correlations to glucocorticoid treatment].
    Zhou T; Fan XM
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):632-5. PubMed ID: 14744400
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuclear factor-kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids.
    Meduri GU; Muthiah MP; Carratu P; Eltorky M; Chrousos GP
    Neuroimmunomodulation; 2005; 12(6):321-38. PubMed ID: 16557033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rational therapeutic regime of glucocorticoid in patients with acute respiratory distress syndrome and its receptor mechanism].
    Ma J
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Nov; 15(11):680-2. PubMed ID: 14604487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids and acute lung injury.
    Thompson BT
    Crit Care Med; 2003 Apr; 31(4 Suppl):S253-7. PubMed ID: 12682449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids.
    Meduri GU; Tolley EA; Chrousos GP; Stentz F
    Am J Respir Crit Care Med; 2002 Apr; 165(7):983-91. PubMed ID: 11934726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of glucocorticoid in the treatment of acute respiratory distress syndrome induced by E.coli].
    Song ZF; Xie W; Shan HM; Guo XH; Sun B
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Dec; 18(12):716-20. PubMed ID: 17166348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Shock lung (ARDS): glucocorticoids?].
    Möllmann HW; Barth J; Schmidt EW; Rohdewald P
    Anasth Intensivther Notfallmed; 1984 Jun; 19(3):99-106. PubMed ID: 6383110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids in ARDS.
    Okamoto H
    N Engl J Med; 2006 Jul; 355(3):317; author reply 318-9. PubMed ID: 16858836
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.
    Meduri GU; Yates CR
    Ann N Y Acad Sci; 2004 Jun; 1024():24-53. PubMed ID: 15265772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-inflammatory therapy in sepsis].
    Briegel J; Weis F; Kilger E
    Chirurg; 2003 Jun; 74(6):590-1; author reply 591-2. PubMed ID: 12916500
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome.
    Marik PE; Meduri GU; Rocco PR; Annane D
    Crit Care Clin; 2011 Jul; 27(3):589-607. PubMed ID: 21742218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid therapy in acute respiratory distress syndrome.
    Gibbs RH
    Br J Hosp Med (Lond); 2009 Nov; 70(11):665. PubMed ID: 20081602
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the host defence response in the progression and outcome of ARDS: pathophysiological correlations and response to glucocorticoid treatment.
    Meduri GU
    Eur Respir J; 1996 Dec; 9(12):2650-70. PubMed ID: 8980983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy.
    Meduri GU; Annane D; Chrousos GP; Marik PE; Sinclair SE
    Chest; 2009 Dec; 136(6):1631-1643. PubMed ID: 19801579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective analysis and evaluation of published articles concerning glucocorticoid therapy for ARDS].
    Lin MF; He QY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):368-70. PubMed ID: 15182457
    [No Abstract]   [Full Text] [Related]  

  • 16. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
    Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal.
    Meduri GU; Kanangat S
    Crit Care Med; 1998 Apr; 26(4):630-3. PubMed ID: 9559593
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery.
    Togo S; Matsuo K; Ishibe A; Nagano Y; Takahashi M; Mochizuki H; Osada S; Kameda K; Shimada H
    Hepatogastroenterology; 2008; 55(84):967-73. PubMed ID: 18705309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS.
    Meduri GU; Carratu P; Freire AX
    Eur Respir J Suppl; 2003 Aug; 42():57s-64s. PubMed ID: 12946002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Report of the consensus conference on diagnostic criteria of ALI/ARDS at high altitudes in Western China.
    Zhang SF; Lin SX; Gao W; Liu HP; Liu Y; Zhang DH; Chen TD; Guo YM; Huang YX
    Intensive Care Med; 2001 Sep; 27(9):1539-46. PubMed ID: 11685349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.